A microRNA negative feedback loop downregulates vesicle transport and inhibits fear memory

  1. Rebecca S Mathew
  2. Antonis Tatarakis
  3. Andrii Rudenko
  4. Erin M Johnson-Venkatesh
  5. Yawei J Yang
  6. Elisabeth A Murphy
  7. Travis P Todd
  8. Scott T Schepers
  9. Nertila Siuti
  10. Anthony J Martorell
  11. William A Falls
  12. Sayamwong E Hammack
  13. Christopher A Walsh
  14. Li-Huei Tsai
  15. Hisashi Umemori
  16. Mark E Bouton
  17. Danesh Moazed  Is a corresponding author
  1. Howard Hughes Medical Institute, Harvard Medical School, United States
  2. The City College of the City University of New York, United States
  3. Harvard Medical School, United States
  4. Howard Hughes Medical Institute, Boston Children's Hospital, United States
  5. University of Vermont, United States
  6. Massachusetts Institute of Technology, United States

Abstract

The SNARE-mediated vesicular transport pathway plays major roles in synaptic remodeling associated with formation of long-term memories, but the mechanisms that regulate this pathway during memory acquisition are not fully understood. Here we identify miRNAs that are up-regulated in the rodent hippocampus upon contextual fear-conditioning and identify the vesicular transport and synaptogenesis pathways as the major targets of the fear-induced miRNAs. We demonstrate that miR-153, a member of this group, inhibits the expression of key components of the vesicular transport machinery, and down-regulates Glutamate receptor A1 trafficking and neurotransmitter release. MiR-153 expression is specifically induced during LTP induction in hippocampal slices and its knockdown in the hippocampus of adult mice results in enhanced fear memory. Our results suggest that miR-153, and possibly other fear-induced miRNAs, act as components of a negative feedback loop that blocks neuronal hyperactivity at least partly through the inhibition of the vesicular transport pathway.

Article and author information

Author details

  1. Rebecca S Mathew

    Department of Cell Biology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Antonis Tatarakis

    Department of Cell Biology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Andrii Rudenko

    Department of Biology, The City College of the City University of New York, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Erin M Johnson-Venkatesh

    Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Yawei J Yang

    Division of Genetics, Howard Hughes Medical Institute, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Elisabeth A Murphy

    Division of Genetics, Howard Hughes Medical Institute, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Travis P Todd

    Department of Psychology, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Scott T Schepers

    Department of Psychology, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8051-7541
  9. Nertila Siuti

    Department of Cell Biology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Anthony J Martorell

    The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. William A Falls

    Department of Psychology, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Sayamwong E Hammack

    Department of Psychology, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Christopher A Walsh

    Division of Genetics, Howard Hughes Medical Institute, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Li-Huei Tsai

    The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Hisashi Umemori

    Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7198-2062
  16. Mark E Bouton

    Department of Psychology, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Danesh Moazed

    Department of Cell Biology, Howard Hughes Medical Institute, Harvard Medical School, Boston, United States
    For correspondence
    danesh@hms.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0321-6221

Funding

Howard Hughes Medical Institute

  • Danesh Moazed

Howard Hughes Medical Institute

  • Christopher A Walsh

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of Harvard Medical School. The protocol was approved by the Committee on the Ethics of Animal Experiments of Harvard Medical School. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.

Copyright

© 2016, Mathew et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,947
    views
  • 739
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rebecca S Mathew
  2. Antonis Tatarakis
  3. Andrii Rudenko
  4. Erin M Johnson-Venkatesh
  5. Yawei J Yang
  6. Elisabeth A Murphy
  7. Travis P Todd
  8. Scott T Schepers
  9. Nertila Siuti
  10. Anthony J Martorell
  11. William A Falls
  12. Sayamwong E Hammack
  13. Christopher A Walsh
  14. Li-Huei Tsai
  15. Hisashi Umemori
  16. Mark E Bouton
  17. Danesh Moazed
(2016)
A microRNA negative feedback loop downregulates vesicle transport and inhibits fear memory
eLife 5:e22467.
https://doi.org/10.7554/eLife.22467

Share this article

https://doi.org/10.7554/eLife.22467

Further reading

    1. Cancer Biology
    2. Cell Biology
    Maojin Tian, Le Yang ... Peiqing Zhao
    Research Article

    TIPE (TNFAIP8) has been identified as an oncogene and participates in tumor biology. However, how its role in the metabolism of tumor cells during melanoma development remains unclear. Here, we demonstrated that TIPE promoted glycolysis by interacting with pyruvate kinase M2 (PKM2) in melanoma. We found that TIPE-induced PKM2 dimerization, thereby facilitating its translocation from the cytoplasm to the nucleus. TIPE-mediated PKM2 dimerization consequently promoted HIF-1α activation and glycolysis, which contributed to melanoma progression and increased its stemness features. Notably, TIPE specifically phosphorylated PKM2 at Ser 37 in an extracellular signal-regulated kinase (ERK)-dependent manner. Consistently, the expression of TIPE was positively correlated with the levels of PKM2 Ser37 phosphorylation and cancer stem cell (CSC) markers in melanoma tissues from clinical samples and tumor bearing mice. In summary, our findings indicate that the TIPE/PKM2/HIF-1α signaling pathway plays a pivotal role in promoting CSC properties by facilitating the glycolysis, which would provide a promising therapeutic target for melanoma intervention.

    1. Cell Biology
    Zewei Zhao, Longyun Hu ... Zhonghan Yang
    Research Article

    The induction of adipose thermogenesis plays a critical role in maintaining body temperature and improving metabolic homeostasis to combat obesity. β3-adrenoceptor (β3-AR) is widely recognized as a canonical β-adrenergic G-protein-coupled receptor (GPCR) that plays a crucial role in mediating adipose thermogenesis in mice. Nonetheless, the limited expression of β3-AR in human adipocytes restricts its clinical application. The objective of this study was to identify a GPCR that is highly expressed in human adipocytes and to explore its potential involvement in adipose thermogenesis. Our research findings have demonstrated that the adhesion G-protein-coupled receptor A3 (ADGRA3), an orphan GPCR, plays a significant role in adipose thermogenesis through its constitutively active effects. ADGRA3 exhibited high expression levels in human adipocytes and mouse brown fat. Furthermore, the knockdown of Adgra3 resulted in an exacerbated obese phenotype and a reduction in the expression of thermogenic markers in mice. Conversely, Adgra3 overexpression activated the adipose thermogenic program and improved metabolic homeostasis in mice without exogenous ligand. We found that ADGRA3 facilitates the biogenesis of beige human or mouse adipocytes in vitro. Moreover, hesperetin was identified as a potential agonist of ADGRA3, capable of inducing adipocyte browning and ameliorating insulin resistance in mice. In conclusion, our study demonstrated that the overexpression of constitutively active ADGRA3 or the activation of ADGRA3 by hesperetin can induce adipocyte browning by Gs-PKA-CREB axis. These findings indicate that the utilization of hesperetin and the selective overexpression of ADGRA3 in adipose tissue could serve as promising therapeutic strategies in the fight against obesity.